MD HB536

Expands the definition of "auto-injectable epinephrine" to "emergency use epinephrine" to include any portable, disposable drug delivery device or product approved by the FDA that contains a premeasured single dose of epinephrine for treating anaphylaxis

Renames the "Emergency Use Auto-Injectable Epinephrine Program" to the "Emergency Use Epinephrine Program" throughout Maryland law

Applies the updated terminology across multiple settings including public schools, nonpublic schools, child care providers, youth camps, food service facilities, and recreation/wellness facilities at higher education institutions

Maintains existing authorization for trained school personnel, certificate holders, and agents to administer emergency use epinephrine to individuals experiencing or believed to be experiencing anaphylaxis

Takes effect July 1, 2025